InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+177.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Geraghty James A, Directeur. Insider active across 3 companies, notably Fulcrum Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €77k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 12 December 2024 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Geraghty James A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1 shares@ US$0.011.0% of flowSeries F Preferred Stock, par value $0.001 per shareSEC:0001437749-24-037353:0
1 shares@ US$1.0099.0% of flowSeries F Preferred Stock, par value $0.001 per shareSEC:0001437749-24-032319:0
Canonical exit: 5 Nov 2024 (T+90)
44,391 sharesOrdinary SharesSEC:0000950170-24-007087:0
10,000 shares@ US$9.16100.0% of flowCommon StockSEC:0000899243-21-026552:0
Canonical exit: 26 Sept 2021 (T+90)
4 of 4 declarations
About Geraghty James A
James A. Geraghty is a Director at Fulcrum Therapeutics, Inc. He plays a key role in the governance of the company, bringing his experience to strengthen its strategy.
